Approximately five to 10 per 100,000 people in the United States carry a gene for AIP, but only 10% of these people ever develop symptoms of the disease.
Swedish porphyria, pyrroloporphyria, and intermittent acute porphyria.
ALA dehydratase deficiency porphyria (step 2); acute intermittent porphyria (step 3); hereditary coproporphyria (step 6); variegate porphyria (step 7).
Hormones (oral contraceptives, menstruation, pregnancy), drugs and dietary factors.
It is a rare disease, estimated to affect fewer than one in one million people.
Lennart Wetterbert has written: 'A neuropsychiatric and genetical investigation of acute intermittent porphyria' -- subject(s): Heredity of disease, Mental illness, Prophyria
Non-acute porphyrias present as chronic diseases.
Most people who inherit the gene for acute porphyria never actually develop symptoms. However, some people will have nausea, muscle fatigue, and purple urine.
Usually do not occur unless triggered by a substance. Attacks feature abdominal pain, nausea, vomiting, constipation, muscle weakness/pain, deep red urine, hallucinations, seizures, mood changes.
While both pyroluria and porphyria involve abnormalities in the heme biosynthesis pathway, they are separate conditions with distinct characteristics. Pyroluria is associated with elevated levels of pyrroles in the urine and is thought to involve zinc and vitamin B6 deficiencies, while porphyria involves defects in enzymes that lead to the accumulation of porphyrins. The two conditions are not directly connected, but both can impact heme production and may have overlapping symptoms.
Porphobilinogen is an intermediate molecule in the biosynthesis of heme, a component of hemoglobin and other proteins. It is produced in the body through a series of enzymatic reactions in the heme biosynthesis pathway. Elevated levels of porphobilinogen can be found in certain conditions like acute intermittent porphyria.
Congenital erythropoietic porphyria (step 4); porphyria cutanea tarda (step 5); hepatoerythopoietic porphyria (step 5); erythropoietic protoporphyria (step 8).
Hepatoerythopoietic porphyria (HEP) affects heme biosynthesis in both the liver and the bone marrow and appears due to inheriting an autosomal recessive gene.